Inter‐individual variation in half‐life of infused recombinant factor VIII is related to pre‐infusion von Willebrand factor antigen levels
- 1 October 1995
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 91 (2) , 474-476
- https://doi.org/10.1111/j.1365-2141.1995.tb05325.x
Abstract
Summary. In an attempt to explain the substantial inter-individual variability in half-life of infused factor VIII (FVIII) among haemophilia A patients, we studied the correlation of pre-infusion von Willebrand factor antigen (vWFAg) levels and the half-life of a recombinant-DNA-derived FVIII (r-VIII SQ, Pharmacia, Sweden). Intra-individual variation in half-life was small (range of variation 0.2-1 h) in 12 severely affected haemophiliacs who received two doses of FVIII concentrate. In contrast, inter-individual variation in half-life was large (range of half-lives 6-28.8 h). A strong correlation between half-life and pre-infusion vWFAg levels was present (r= 0.87, P= 0.0003). We conclude that the half-life of infused recombinant FVIII is related to pre-infusion vWFAg levels in severely affected haemophilia A patients.Keywords
This publication has 10 references indexed in Scilit:
- Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP‐induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factorBritish Journal of Haematology, 1994
- Pharmacokinetic dosing in prophylactic treatment of hemophilia AEuropean Journal of Haematology, 1993
- Pharmacokinetics of Monoclonally-Purified and Recombinant Factor VIII in Patients with Severe von Willebrand DiseaseThrombosis and Haemostasis, 1993
- The Design and Analysis of Half-Life and Recovery Studies for Factor VIII and Factor IXThrombosis and Haemostasis, 1991
- Characterization of human factor VIII and interaction with von Willebrand factorEuropean Journal of Biochemistry, 1990
- The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIIIBiochemical Journal, 1989
- Multi-variate analysis of factors governing the pharmacokinetics of exogenous factor VIII in haemophiliacsEuropean Journal of Clinical Pharmacology, 1988
- Clinical Pharmacokinetics of Factor VIII in Patients with Classic HaemophiliaClinical Pharmacokinetics, 1987
- Factor VIII: C (FVIII: C) Recovery and Half-Life After Infusion of Steam-Treated High Purity Factor VIII Concentrate in Severe Hemophilia A - Comparison of One-Stage Assay, Two-Stage Assay and a Chromogenic Substrate AssayThrombosis and Haemostasis, 1986